投資家の PDS Planning Incと Signaturefd LLCは 薬剤の大手企業である 竹田製薬の株式を拡大しました Investors PDS Planning Inc and Signaturefd LLC have boosted their holdings in Takeda Pharmaceutical, a major drugmaker.

PDS Planning IncとSignaturefd LLCは 腫瘍学や胃腸学などの分野を専門とする グローバル製薬会社であるTakeda Pharmaceutical Company Limitedの株式を拡大しました PDS Planning Inc and Signaturefd LLC have increased their stakes in Takeda Pharmaceutical Company Limited, a global pharmaceutical company specializing in areas like oncology and gastroenterology. 株式価格は15.14ドル,市場資本は4816億ドル,P/E比は37.84です. Takeda's stock price is $15.14, with a market cap of $48.16 billion and a P/E ratio of 37.84. 最新の四半期の1株当たりの収益は0.42ドルで,その期待を上回る額は0.08. Earnings per share for the latest quarter were $0.42, exceeding expectations by $0.08. 分析者は今年に 株当たり1.64の利益を予測している Analysts predict 1.64 earnings per share for this year.